Platelet Biogenesis specializes in allogeneic cell therapy focused on the production and enhancement of platelets derived from stem cells. This technology addresses the critical shortage of platelets for transfusions and therapeutic applications, improving patient outcomes in various medical conditions.
Funding
Funding not disclosed
Founders
Product
Problem
There is a critical shortage of platelets available for transfusions and therapeutic applications. This shortage can negatively impact patient outcomes across various medical conditions.
Solution
Platelet Biogenesis focuses on allogeneic cell therapy to produce and enhance platelets derived from stem cells. Their technology aims to address the platelet shortage by providing a scalable and reliable source of platelets for transfusions. By leveraging stem cell technology, they offer a potential solution to meet the growing demand for platelets in various medical settings. This approach has the potential to improve patient outcomes by ensuring a more readily available supply of platelets.
Target Audience
Hospitals, transfusion centers, and research institutions requiring a reliable supply of platelets for patient care and therapeutic applications are the primary customers.
Features
- Allogeneic cell therapy for platelet production
- Stem cell-derived platelets
- Scalable platelet production process